Ignite Creation Date:
2025-12-26 @ 10:58 AM
Ignite Modification Date:
2025-12-31 @ 10:49 PM
Study NCT ID:
NCT05232006
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-03-08
First Post:
2022-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PARP-inhibitor on Advanced Metastatic Breast Cancer in Germline PALB2 Mutations Carriers
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-05
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-28
First Submit QC Date:
None
Study First Post Date:
2022-02-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-21
Last Update Post Date:
2022-03-08
Last Update Post Date Type:
ACTUAL